Ten years after the completion of the first draft of the human genome sequence, the field of personalized genomic medicine is emerging. Affordable gene mapping -- and, in the near future, affordable whole genome sequencing -- is available for individuals who want to determine their genetic risks. The resulting information has the potential to help physicians diagnose and treat diseases. For this event, a panel of medical practitioners and policy experts will review the success of the Human Genome Project and examine the future of personalized medicine, the policy challenges and the economic costs. This discussion is the third event in the Medicine, Research and Society Policy Issues Series, a joint project between the Baker Institute Science and Technology Policy Program and The University of Texas MD Anderson Cancer Center.